Pharmaceutical lobby sues Trump administration over most favored nation pricing
The pharmaceutical industry's top lobby group, PhRMA, has sued to invalidate a Trump administration rule that aims to benchmark US drug prices to lower costs overseas in the Medicare health insurance program. The rule, known as the GLOBE rule or most favored nation pricing system, intends to set hospital drug prices for Medicare patients. The lawsuit argues that the rule is an illegal overreach by the US government.
Listen to Live Briefing
Real-time synthesized voice briefing · Live Feeds Desk
- ✓ The pharmaceutical industry's top lobby group sued to invalidate a Trump administration rule.
- ✓ The rule aims to benchmark US drug prices to lower costs overseas in the Medicare health insurance program.
- ✓ The GLOBE rule intends to set hospital drug prices for Medicare patients.
- ✓ The lawsuit argues that the rule is an illegal overreach by the US government.
What changed
The pharmaceutical lobby group PhRMA filed a lawsuit against the Trump administration over the GLOBE rule on Medicare drug prices.
Live updates
-
Pharmaceutical lobby sues Trump administration over drug pricing
The pharmaceutical industry's top lobby group, PhRMA, has sued to invalidate a Trump administration rule that aims to benchmark US drug prices to lower costs overseas in the Medicare health insurance program. The rule, known as the GLOBE rule or most favored nation pricing system, intends to set hospital drug prices for Medicare patients. The lawsuit argues that the rule is an illegal overreach by the US government.
Why it matters
The Trump administration's efforts to reduce drug prices have been met with resistance from the pharmaceutical industry. The GLOBE rule is part of a larger effort to lower costs for Medicare patients. The pharmaceutical lobby group claims that the rule is illegal and will have limited reach, potentially applying to as few as four drugmakers.
What is confirmed
- The pharmaceutical industry's top lobby group sued to invalidate a Trump administration rule.
- The rule aims to benchmark US drug prices to lower costs overseas in the Medicare health insurance program.
- The GLOBE rule intends to set hospital drug prices for Medicare patients.
- The lawsuit argues that the rule is an illegal overreach by the US government.
- The rule may apply to as few as four drugmakers.
What to watch next
- The outcome of the lawsuit filed by PhRMA against the Trump administration
- The implementation of the GLOBE rule and its impact on Medicare drug prices
- The Trump administration's response to the lawsuit and potential revisions to the rule
confidence 100%Sources used for this update (17)
- www.nintendo.com — Nintendo Store – Nintendo Official Site
- ny1.com — NYC sues over rule change for immigrants using public aid
- economictimes.indiatimes.com — Dow Jones| Nasdaq | US Stock Market Today | Live: Dow tumbles over 550 pts as Mideast tensions push oil above $100
- Yahoo — Pharmaceutical lobby sues Trump administration over most favored nation pricing
- Reuters — Pharma lobby sues Trump administration over Medicare drug price cuts
- STAT — PhRMA sues over Trump policy mandating lower drug prices in Medicare
- factcheck.org — Trump Touts Medicaid Drug Savings, But Details Remain Murky
- Seeking Alpha — Pharma lobby group sues Trump administration over MFN pricing
- wattsupwiththat.com — Weekly Climate and Energy News Roundup #709 - Watts Up With That?
- www.yahoo.com — Pharmaceutical lobby sues Trump administration over most favored nation pricing
- www.maisonfleurhoian.com — Top 9 Romantic Restaurants in Hoi An for an Unforgettable Dinner...
- hoiandaytrip.com — Best Restaurants in Hoi An Old Town With A View
Community Sentiment: How do you assess this situation?
Voice your perspective · Real-time aggregated sentiment from the Live Feeds community